| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |